Breaking News

BMS Buys Land for New Biologics Facility

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol-Myers Squibb has completed the land purchase of an 89-acre site from MassDevelopment for its new large-scale multi-product bulk biologics manufacturing facility in Devens, MA. The two companies have also finalized agreements related to the facility’s utility infrastructure, including waste water treatment, use of electricity, water, and natural gas. Construction on the facility is expected to begin in the next several weeks, and is projected to be operational in 2009. The company p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters